Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Male hormones worsen kidney transplant damage, but blocking them helps.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

Hair loss and excessive growth treated with various options, including new laser technology.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Perifollicular fibrosis hinders hair regrowth in androgenetic alopecia, and new treatments targeting fibrosis are needed.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.